Loading…
Diversity of regulatory CD4 super(+T) cells controlling distinct organ-specific autoimmune diseases
Depletion of selected regulatory CD4 super(+) T cell subsets induces the spontaneous onset of various immune or autoimmune disorders. It is not clear, however, whether a given subset, notably CD4 super(+)CD25 super(+) regulatory T cells, protects from a wide spectrum of immune disorders, or whether...
Saved in:
Published in: | Proceedings of the National Academy of Sciences - PNAS 2003-12, Vol.100 (26), p.15806-15811 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 15811 |
container_issue | 26 |
container_start_page | 15806 |
container_title | Proceedings of the National Academy of Sciences - PNAS |
container_volume | 100 |
creator | Alyanakian, M-A You, S Damotte, D Gouarin, C Esling, A Garcia, C Havouis, S Chatenoud, L Bach, J-F |
description | Depletion of selected regulatory CD4 super(+) T cell subsets induces the spontaneous onset of various immune or autoimmune disorders. It is not clear, however, whether a given subset, notably CD4 super(+)CD25 super(+) regulatory T cells, protects from a wide spectrum of immune disorders, or whether specialized subsets of regulatory T cells control each given disease or group of diseases. We report here, using diabetes prone nonobese diabetic (NOD) mice, that depending on the regulatory T cells that are depleted, i.e., CD25 super(+), CD62L super(+), or CD45RB super(low), distinct immune diseases appear after transfer into NOD severe combined immunodeficiency (SCID) recipients. Thus, reconstitution of NOD SCID mice with CD25 super(-) T cells induces major gastritis and late-onset diabetes, but no or mild colitis. Reconstitution with CD62L super(-) T cells induces fulminant diabetes with no colitis or gastritis. Reconstitution with CD45RB super(high) T cells induces major colitis with wasting disease and no or very moderate gastritis and diabetes. Major differences among the three regulatory T cell subsets are also seen in vitro. The bulk of suppressor cells inhibiting the proliferation of CD4 super(+)CD25 super(-) T cells in coculture is concentrated within the CD25 super(+) but not the CD62L super(+) or CD45RB super(low) T cell subsets. Similarly, cytokine production patterns are significantly different for each regulatory T cell subset. Collectively, these data point to the diversity and organ selectivity of regulatory T cells controlling distinct autoimmune diseases whatever the underlying mechanisms. |
doi_str_mv | 10.1073/pnas.2636971100 |
format | article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_19260470</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19260470</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_192604703</originalsourceid><addsrcrecordid>eNqNzc1KAzEUQOEgCo7atdu7EqVMezMTZ5p1f_ABui8hvTOkZJIxNxH69lLwAVydzQdHiFeJK4l9u56D4VXTtZ3upUS8E5VELetOabwXFWLT1xvVqEfxxHxBRP25wUrYnfuhxC5fIQ6QaCze5JiusN0p4DJTel8eP8CS9ww2hpyi9y6McHacXbAZYhpNqHkm6wZnwZQc3TSVQDdCholfxMNgPNPir8_i7bA_br_qOcXvQpxPk-PbwQSKhU9SNx2qHtt_w19G9lBV</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19260470</pqid></control><display><type>article</type><title>Diversity of regulatory CD4 super(+T) cells controlling distinct organ-specific autoimmune diseases</title><source>PMC (PubMed Central)</source><source>JSTOR Archival Journals and Primary Sources Collection</source><creator>Alyanakian, M-A ; You, S ; Damotte, D ; Gouarin, C ; Esling, A ; Garcia, C ; Havouis, S ; Chatenoud, L ; Bach, J-F</creator><creatorcontrib>Alyanakian, M-A ; You, S ; Damotte, D ; Gouarin, C ; Esling, A ; Garcia, C ; Havouis, S ; Chatenoud, L ; Bach, J-F</creatorcontrib><description>Depletion of selected regulatory CD4 super(+) T cell subsets induces the spontaneous onset of various immune or autoimmune disorders. It is not clear, however, whether a given subset, notably CD4 super(+)CD25 super(+) regulatory T cells, protects from a wide spectrum of immune disorders, or whether specialized subsets of regulatory T cells control each given disease or group of diseases. We report here, using diabetes prone nonobese diabetic (NOD) mice, that depending on the regulatory T cells that are depleted, i.e., CD25 super(+), CD62L super(+), or CD45RB super(low), distinct immune diseases appear after transfer into NOD severe combined immunodeficiency (SCID) recipients. Thus, reconstitution of NOD SCID mice with CD25 super(-) T cells induces major gastritis and late-onset diabetes, but no or mild colitis. Reconstitution with CD62L super(-) T cells induces fulminant diabetes with no colitis or gastritis. Reconstitution with CD45RB super(high) T cells induces major colitis with wasting disease and no or very moderate gastritis and diabetes. Major differences among the three regulatory T cell subsets are also seen in vitro. The bulk of suppressor cells inhibiting the proliferation of CD4 super(+)CD25 super(-) T cells in coculture is concentrated within the CD25 super(+) but not the CD62L super(+) or CD45RB super(low) T cell subsets. Similarly, cytokine production patterns are significantly different for each regulatory T cell subset. Collectively, these data point to the diversity and organ selectivity of regulatory T cells controlling distinct autoimmune diseases whatever the underlying mechanisms.</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.2636971100</identifier><language>eng</language><ispartof>Proceedings of the National Academy of Sciences - PNAS, 2003-12, Vol.100 (26), p.15806-15811</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Alyanakian, M-A</creatorcontrib><creatorcontrib>You, S</creatorcontrib><creatorcontrib>Damotte, D</creatorcontrib><creatorcontrib>Gouarin, C</creatorcontrib><creatorcontrib>Esling, A</creatorcontrib><creatorcontrib>Garcia, C</creatorcontrib><creatorcontrib>Havouis, S</creatorcontrib><creatorcontrib>Chatenoud, L</creatorcontrib><creatorcontrib>Bach, J-F</creatorcontrib><title>Diversity of regulatory CD4 super(+T) cells controlling distinct organ-specific autoimmune diseases</title><title>Proceedings of the National Academy of Sciences - PNAS</title><description>Depletion of selected regulatory CD4 super(+) T cell subsets induces the spontaneous onset of various immune or autoimmune disorders. It is not clear, however, whether a given subset, notably CD4 super(+)CD25 super(+) regulatory T cells, protects from a wide spectrum of immune disorders, or whether specialized subsets of regulatory T cells control each given disease or group of diseases. We report here, using diabetes prone nonobese diabetic (NOD) mice, that depending on the regulatory T cells that are depleted, i.e., CD25 super(+), CD62L super(+), or CD45RB super(low), distinct immune diseases appear after transfer into NOD severe combined immunodeficiency (SCID) recipients. Thus, reconstitution of NOD SCID mice with CD25 super(-) T cells induces major gastritis and late-onset diabetes, but no or mild colitis. Reconstitution with CD62L super(-) T cells induces fulminant diabetes with no colitis or gastritis. Reconstitution with CD45RB super(high) T cells induces major colitis with wasting disease and no or very moderate gastritis and diabetes. Major differences among the three regulatory T cell subsets are also seen in vitro. The bulk of suppressor cells inhibiting the proliferation of CD4 super(+)CD25 super(-) T cells in coculture is concentrated within the CD25 super(+) but not the CD62L super(+) or CD45RB super(low) T cell subsets. Similarly, cytokine production patterns are significantly different for each regulatory T cell subset. Collectively, these data point to the diversity and organ selectivity of regulatory T cells controlling distinct autoimmune diseases whatever the underlying mechanisms.</description><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqNzc1KAzEUQOEgCo7atdu7EqVMezMTZ5p1f_ABui8hvTOkZJIxNxH69lLwAVydzQdHiFeJK4l9u56D4VXTtZ3upUS8E5VELetOabwXFWLT1xvVqEfxxHxBRP25wUrYnfuhxC5fIQ6QaCze5JiusN0p4DJTel8eP8CS9ww2hpyi9y6McHacXbAZYhpNqHkm6wZnwZQc3TSVQDdCholfxMNgPNPir8_i7bA_br_qOcXvQpxPk-PbwQSKhU9SNx2qHtt_w19G9lBV</recordid><startdate>20031223</startdate><enddate>20031223</enddate><creator>Alyanakian, M-A</creator><creator>You, S</creator><creator>Damotte, D</creator><creator>Gouarin, C</creator><creator>Esling, A</creator><creator>Garcia, C</creator><creator>Havouis, S</creator><creator>Chatenoud, L</creator><creator>Bach, J-F</creator><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20031223</creationdate><title>Diversity of regulatory CD4 super(+T) cells controlling distinct organ-specific autoimmune diseases</title><author>Alyanakian, M-A ; You, S ; Damotte, D ; Gouarin, C ; Esling, A ; Garcia, C ; Havouis, S ; Chatenoud, L ; Bach, J-F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_192604703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alyanakian, M-A</creatorcontrib><creatorcontrib>You, S</creatorcontrib><creatorcontrib>Damotte, D</creatorcontrib><creatorcontrib>Gouarin, C</creatorcontrib><creatorcontrib>Esling, A</creatorcontrib><creatorcontrib>Garcia, C</creatorcontrib><creatorcontrib>Havouis, S</creatorcontrib><creatorcontrib>Chatenoud, L</creatorcontrib><creatorcontrib>Bach, J-F</creatorcontrib><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alyanakian, M-A</au><au>You, S</au><au>Damotte, D</au><au>Gouarin, C</au><au>Esling, A</au><au>Garcia, C</au><au>Havouis, S</au><au>Chatenoud, L</au><au>Bach, J-F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diversity of regulatory CD4 super(+T) cells controlling distinct organ-specific autoimmune diseases</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><date>2003-12-23</date><risdate>2003</risdate><volume>100</volume><issue>26</issue><spage>15806</spage><epage>15811</epage><pages>15806-15811</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><abstract>Depletion of selected regulatory CD4 super(+) T cell subsets induces the spontaneous onset of various immune or autoimmune disorders. It is not clear, however, whether a given subset, notably CD4 super(+)CD25 super(+) regulatory T cells, protects from a wide spectrum of immune disorders, or whether specialized subsets of regulatory T cells control each given disease or group of diseases. We report here, using diabetes prone nonobese diabetic (NOD) mice, that depending on the regulatory T cells that are depleted, i.e., CD25 super(+), CD62L super(+), or CD45RB super(low), distinct immune diseases appear after transfer into NOD severe combined immunodeficiency (SCID) recipients. Thus, reconstitution of NOD SCID mice with CD25 super(-) T cells induces major gastritis and late-onset diabetes, but no or mild colitis. Reconstitution with CD62L super(-) T cells induces fulminant diabetes with no colitis or gastritis. Reconstitution with CD45RB super(high) T cells induces major colitis with wasting disease and no or very moderate gastritis and diabetes. Major differences among the three regulatory T cell subsets are also seen in vitro. The bulk of suppressor cells inhibiting the proliferation of CD4 super(+)CD25 super(-) T cells in coculture is concentrated within the CD25 super(+) but not the CD62L super(+) or CD45RB super(low) T cell subsets. Similarly, cytokine production patterns are significantly different for each regulatory T cell subset. Collectively, these data point to the diversity and organ selectivity of regulatory T cells controlling distinct autoimmune diseases whatever the underlying mechanisms.</abstract><doi>10.1073/pnas.2636971100</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0027-8424 |
ispartof | Proceedings of the National Academy of Sciences - PNAS, 2003-12, Vol.100 (26), p.15806-15811 |
issn | 0027-8424 1091-6490 |
language | eng |
recordid | cdi_proquest_miscellaneous_19260470 |
source | PMC (PubMed Central); JSTOR Archival Journals and Primary Sources Collection |
title | Diversity of regulatory CD4 super(+T) cells controlling distinct organ-specific autoimmune diseases |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T04%3A54%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diversity%20of%20regulatory%20CD4%20super(+T)%20cells%20controlling%20distinct%20organ-specific%20autoimmune%20diseases&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Alyanakian,%20M-A&rft.date=2003-12-23&rft.volume=100&rft.issue=26&rft.spage=15806&rft.epage=15811&rft.pages=15806-15811&rft.issn=0027-8424&rft.eissn=1091-6490&rft_id=info:doi/10.1073/pnas.2636971100&rft_dat=%3Cproquest%3E19260470%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_miscellaneous_192604703%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19260470&rft_id=info:pmid/&rfr_iscdi=true |